Company Announcements


Source: RNS
RNS Number : 9971C
Unite Group PLC (The)
14 October 2022

THE UNITE GROUP PLC (the "Company")


14 October 2022




Scrip Scheme elections were received in respect of 11,064,400 shares representing a take up of approximately 2.77% of the Company's share capital. This will result in the issue of 100,447 new ordinary shares (approximately 0.03% of the current issued share capital).  These shares will be issued at a price of 970.50 pence each (this being the Scrip Reference Share Price announced on 23 September 2022). These shares will rank pari passu in all respects with the Company's existing issued ordinary shares.

Applications will be made to the UK Financial Conduct Authority for these shares to be admitted to the Premium Segment of the Official List and to the London Stock Exchange for these shares to be admitted to trading on the Main Market for listed securities. It is expected that admission will occur on 28 October 2022.

Following the issue of these shares, the total number of shares in issue and voting rights in the Company will be 400,233,995 with effect from 28 October 2022. This may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Share certificates will be posted to certificated shareholders who elected for scrip dividend shares and shareholders holding shares in CREST, who elected for scrip dividend shares, will have their CREST accounts credited directly on 28 October 2022.


Details of the scrip scheme can be found on the Company's website at




For further information, please contact:



Unite Students

Christopher Szpojnarowicz, Company Secretary                                      Tel: +44 117 302 7120   



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.